Toxikon is a prominent supplier to the pharmaceutical industry, specialising in a wide array of services that cater to the needs of drug development and research. The company offers a comprehensive range of solutions designed to support various stages of pharmaceutical research, ensuring compliance with regulatory standards and optimising product efficacy and safety. With a commitment to scientific excellence, Toxikon aids clients in navigating the complexities of drug development processes.

Services include:
- Accelerated Stability Studies
- ADMET
- Analytical Services
- Assay Development
- Bioanalytical Services
- Biological Testing
- Cell Culture Media Development
- Chemical Analysis
- Chromatography
- Contaminant Analysis
- Contract Research (CRO)
- Custom Manufacturing
- Drug Development
- Contract Development
- Efficacy Testing
- Testing
- Process Development
- Formulation Development
- Immunobiology Services
- Immunotoxicity Testing
- In Vitro Testing
- IND/NDA Submissions
- Mass Spectrometry
- Materials Analysis
- Metabolic Analysis
- Microbiological Testing
- Pharmacokinetics
- Pharmacology
- Photostability
- Preclinical Study Design
- Preclinical Testing
- Preclinical Testing Formulations
- Quality QA/QC
- R&D Services
- Radiopharmaceuticals
- Raw Materials Analysis
- Stability Studies
- Stability
- ICH
- Sterility Testing
- Toxicology Services & Analysis
- Trace Metal Analysis
- ICP
- UV-VIS Spectrophotometer Analysis
- Wet Chemical Analysis

Toxikon remains a pivotal player in the pharmaceutical supply sector, offering invaluable support to clients aiming to bring safe and effective products to market. For more information, please visit toxikon.com.